Aminosteroid RM-581 Decreases Cell Proliferation of All Breast Cancer Molecular Subtypes, Alone and in Combination with Breast Cancer Treatments.

Burguin, Anna; Roy, Jenny; Ouellette, Geneviève; Maltais, René; Bherer, Juliette; Diorio, Caroline; Poirier, Donald; Durocher, Francine

Burguin, Anna; Roy, Jenny; Ouellette, Geneviève; Maltais, René; Bherer, Juliette; Diorio, Caroline; Poirier, Donald; Durocher, Francine.

Afiliação

Burguin A; Department of Molecular Medicine, Faculty of Medicine, Université Laval, Québec, QC GIV 0A6, Canada.
Roy J; Cancer Research Centre, CHU de Québec-Research Centre, Québec, QC G1R 3S3, Canada.
Ouellette G; Cancer Research Centre, CHU de Québec-Research Centre, Québec, QC G1R 3S3, Canada.
Maltais R; Laboratory of Medicinal Chemistry, Endocrinology and Nephrology Unit, CHU de Québec-Research Center, Québec, QC G1V 4G2, Canada.
Bherer J; Department of Molecular Medicine, Faculty of Medicine, Université Laval, Québec, QC GIV 0A6, Canada.
Diorio C; Cancer Research Centre, CHU de Québec-Research Centre, Québec, QC G1R 3S3, Canada.
Poirier D; Cancer Research Centre, CHU de Québec-Research Centre, Québec, QC G1R 3S3, Canada.
Durocher F; Laboratory of Medicinal Chemistry, Endocrinology and Nephrology Unit, CHU de Québec-Research Center, Québec, QC G1V 4G2, Canada.

J Clin Med ; 12(13)2023 Jun 24.

Article em En | MEDLINE | ID: mdl-37445276

Palavras-chave

aminosteroid; breast cancer; breast cancer treatment; endoplasmic reticulum stress; personalized therapy; spheroid; triple-negative breast cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Clin Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Canadá

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google